Recruiting
A Study of Abatacept in Participants That Only Recently Started to Develop Rheumatoid Arthritis - IM101-679
Actualizada: 2 abril, 2018 | ClinicalTrials.gov
Imprimir Resumen
Detalles del ensayo
Género(s)
Rango de edad
Ubicación(es)
Recruiting
Opciones de tratamiento
Inclusion Criteria: - Participants recently (within the last 24 months before enrollment) diagnosed with established moderate to severe active RA - Participants naïve of abatacept and who, at their physician's discretion, are initiated with abatacept according the German label/SmPC (Summary of product characteristics) Exclusion Criteria: - Participants who are currently included in any interventional clinical trial in RA Other protocol defined inclusion/exclusion criteria could apply
Recomendamos encarecidamente que se comunique con BMS para informar los efectos secundarios (eventos adversos)
Los efectos secundarios (eventos adversos) y otros eventos reportables se definen aquí
Informe de efectos secundarios (eventos adversos) o quejas sobre la calidad del producto: información médica
